0001104659-20-072742.txt : 20200612 0001104659-20-072742.hdr.sgml : 20200612 20200612114757 ACCESSION NUMBER: 0001104659-20-072742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harshbarger Benjamin CENTRAL INDEX KEY: 0001653133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 20959472 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2020-06-11 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001653133 Harshbarger Benjamin C/O CATABASIS PHARMACEUTICALS, INC., 100 HIGH STREET, FLOOR 28 BOSTON MA 02110 0 1 0 0 Secretary and General Counsel Stock Option (right to buy) 6.17 2020-06-11 4 A 0 45000 0 A 2030-06-10 Common Stock 45000 45000 D This option was granted on June 11, 2020 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. /s/ Jill Milne, as attorney-in-fact for Benjamin Harshbarger 2020-06-12